Skip to main navigation Skip to search Skip to main content

ICON Clinical Research: A Phase 3, Randomized, Double-Or-Observer-Blined, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of a Respiratory Syncytial Virus (RSV) Prefusion F Subunit Vaccine in Infants Born to Women Vaccinated...

Project: Research

Project Details

StatusFinished
Effective start/end date08/14/2012/23/22

Funding

  • Pfizer Incorporated: $19,000.00